292 related articles for article (PubMed ID: 36509421)
1. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study.
Wissel K; Vernazza P; Kuster S; Hensel-Koch K; Bregenzer A
Swiss Med Wkly; 2024 Feb; 154():3352. PubMed ID: 38579293
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
[TBL] [Abstract][Full Text] [Related]
5. Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada.
Wolfson-Stofko B; Hirode G; Vanderhoff A; Karkada J; Capraru C; Biondi MJ; Hansen B; Shah H; Janssen HLA; Feld JJ
J Viral Hepat; 2024 May; 31(5):240-247. PubMed ID: 38385850
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study.
Schürch S; Fux CA; Dehler S; Conen A; Knuchel J; Friedl A; Eigenmann F; Roser P; Ackle P; Bregenzer A
Swiss Med Wkly; 2020 Jul; 150():w20317. PubMed ID: 32799310
[TBL] [Abstract][Full Text] [Related]
7. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
Bregenzer A; Warmann N; Ottiger C; Fux CA
Swiss Med Wkly; 2019 Oct; 149():w20137. PubMed ID: 31656039
[TBL] [Abstract][Full Text] [Related]
8. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
9. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study.
Sanvisens A; Rivas I; Faure E; Espinach N; Hernandez-Rubio A; Majó X; Colom J; Muga R
World J Gastroenterol; 2020 Oct; 26(38):5874-5883. PubMed ID: 33132641
[TBL] [Abstract][Full Text] [Related]
10. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
[TBL] [Abstract][Full Text] [Related]
12. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
13. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
[TBL] [Abstract][Full Text] [Related]
14. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS
Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of an HCV elimination program targeting the Viennese MSM population.
Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T
Wien Klin Wochenschr; 2021 Jul; 133(13-14):635-640. PubMed ID: 34181068
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].
Cifuentes C; Mira JA; Vargas J; Neukam K; Escassi C; García-Rey S; Gilabert I; González-Monclova M; Bernal S; Pineda JA
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):452-7. PubMed ID: 22541340
[TBL] [Abstract][Full Text] [Related]
17. Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
Baumann L; Braun DL; Cavassini M; Stoeckle M; Bernasconi E; Schmid P; Calmy A; Haerry D; Béguelin C; Fux CA; Wandeler G; Surial B; Rauch A
Liver Int; 2024 Jan; 44(1):169-179. PubMed ID: 37850685
[TBL] [Abstract][Full Text] [Related]
18. Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial.
Byrne CJ; Radley A; Inglis SK; Beer L; Palmer N; Duc Pham M; Allardice K; Wang H; Robinson E; Hermansson M; Semizarov D; Healy B; Doyle JS; Dillon JF
Aliment Pharmacol Ther; 2022 Jun; 55(12):1512-1523. PubMed ID: 35538396
[TBL] [Abstract][Full Text] [Related]
19. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
20. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
